Electrical Prescriptions (ElectRx)

Competitively awarded basic research and development contract with goals, objectives, specifications that will attempt to prove the scientific or engineering concepts in question, with cost estimates that are insufficient to permit use of a fixed price contract. Also, the contract will not mature sufficiently to transition to a firm fixed price contract while the program is managed at DARPA.

MODIFICATION 1 - The purpose of Modification 1 to DARPA-BAA-15-06, the Electrical Prescriptions (ElectRx) Broad Agency Announcement, is to clarify the FAQ location.

DARPA will post a consolidated question and answer document (FAQ) to http://www.darpa.mil/Opportunities/Solicitations/BTO_Solicitations.aspx. Submit your question/s by E-mail to DARPA-BAA-15-06@darpa.mil. In order to receive a response, send your question/s by 13 February 2015.

The DARPA ElectRx program seeks innovative research proposals for creating closed-loop neuromodulation systems that utilize innate neurophysiological circuits to achieve therapeutic benefits. To achieve this goal, ElectRx will simultaneously drive biological understanding and technology development. Specifically, ElectRx is looking to develop and leverage fundamental understanding of the anatomy and physiology of neural circuits in the spinal cord or peripheral nerves that mediate health status.  This knowledge will be leveraged to design and demonstrate feedback-controlled neuromodulation systems for the direct regulation of immune system functions and CNS disorders. In parallel, technology development focused on next-generation minimally-invasive neural interfaces and biosensors will enable interaction with the neurophysiology of interest at unmatched spatiotemporal resolution, precision, and specificity. These neuromodulation treatments will be tuned automatically and continuously to the unique physiology of each individual and will produce no off-target effects.  Additional information set forth in attached BAA.